Jiangsu Aoyang Health Industry Co.ltd.

SZSE:002172 Rapporto sulle azioni

Cap. di mercato: CN¥2.3b

Jiangsu Aoyang Health Industryltd Performance dei guadagni passati

Il passato criteri di controllo 3/6

Jiangsu Aoyang Health Industryltd has been growing earnings at an average annual rate of 41.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 9.2% per year. Jiangsu Aoyang Health Industryltd's return on equity is 44%, and it has net margins of 2.4%.

Informazioni chiave

41.7%

Tasso di crescita degli utili

40.9%

Tasso di crescita dell'EPS

Chemicals Crescita del settore12.1%
Tasso di crescita dei ricavi-9.2%
Rendimento del capitale proprio44.0%
Margine netto2.4%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

We Believe Jiangsu Aoyang Health Industryltd's (SZSE:002172) Earnings Are A Poor Guide For Its Profitability

Sep 04
We Believe Jiangsu Aoyang Health Industryltd's (SZSE:002172) Earnings Are A Poor Guide For Its Profitability

Recent updates

We Believe Jiangsu Aoyang Health Industryltd's (SZSE:002172) Earnings Are A Poor Guide For Its Profitability

Sep 04
We Believe Jiangsu Aoyang Health Industryltd's (SZSE:002172) Earnings Are A Poor Guide For Its Profitability

There's No Escaping Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Muted Revenues

Feb 29
There's No Escaping Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Muted Revenues

Ripartizione dei ricavi e delle spese

Come Jiangsu Aoyang Health Industryltd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SZSE:002172 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 242,05149184-2
30 Jun 242,14252183-1
31 Mar 242,212441870
31 Dec 232,174501920
30 Sep 231,965-11542
30 Jun 232,050-261861
31 Mar 231,922-121930
01 Jan 232,021-151530
30 Sep 226791362710
30 Jun 22695113230
31 Mar 221,098-8033650
01 Jan 221,429-8004230
30 Sep 212,183-742377-2
30 Jun 212,307-692367-1
31 Mar 212,2261223760
31 Dec 201,885-353811
30 Sep 202,692-3374374
30 Jun 202,611-3454444
31 Mar 202,665-4935083
31 Dec 192,982-42552021
30 Sep 193,357-30746462
30 Jun 193,839-19940277
31 Mar 194,487-6533776
31 Dec 184,7111033057
30 Sep 185,126835816
30 Jun 185,353773560
31 Mar 185,2981163550
31 Dec 175,3721543610
30 Sep 175,4212293160
30 Jun 175,2792623390
31 Mar 175,0862863190
31 Dec 164,8762593110
30 Sep 164,4892463190
30 Jun 164,1331873160
31 Mar 163,9161683290
31 Dec 153,8091363300
30 Sep 155,203694320
30 Jun 155,090164070
31 Mar 154,982-383810
31 Dec 144,676-723550
30 Sep 143,109-662270
30 Jun 143,120-502270
31 Mar 143,131-282230
31 Dec 133,277212370

Guadagni di qualità: 002172 has high quality earnings.

Margine di profitto in crescita: 002172 became profitable in the past.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 002172 has become profitable over the past 5 years, growing earnings by 41.7% per year.

Accelerare la crescita: 002172 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Guadagni vs Settore: 002172 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).


Rendimento del capitale proprio

ROE elevato: Whilst 002172's Return on Equity (44.03%) is outstanding, this metric is skewed due to their high level of debt.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate